Search for other papers by Karolien Van De Maele in
Google Scholar
PubMed
Search for other papers by Jean De Schepper in
Google Scholar
PubMed
Search for other papers by Jesse Vanbesien in
Google Scholar
PubMed
Search for other papers by Monique Van Helvoirt in
Google Scholar
PubMed
Search for other papers by Ann De Guchtenaere in
Google Scholar
PubMed
Search for other papers by Inge Gies in
Google Scholar
PubMed
the predictive value of the vitamin D status in body fat loss in obese adolescents during a residential weight loss program. We hypothesized that adolescents with a low baseline vitamin D level would be at risk for less effective weight loss during the
Search for other papers by Monika Karczewska-Kupczewska in
Google Scholar
PubMed
Search for other papers by Agnieszka Nikołajuk in
Google Scholar
PubMed
Search for other papers by Radosław Majewski in
Google Scholar
PubMed
Search for other papers by Remigiusz Filarski in
Google Scholar
PubMed
Search for other papers by Magdalena Stefanowicz in
Google Scholar
PubMed
Search for other papers by Natalia Matulewicz in
Google Scholar
PubMed
Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
Results. Differences between the groups were analyzed with the unpaired Student’s t -test. Differences in the estimated parameters before and after weight loss program in the entire obese group were assessed with the paired Student’s t -test. Differences
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alberto Sánchez-Guijo in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Stefan A Wudy in
Google Scholar
PubMed
concentrations are linked with weight status in obese children since substantial weight loss in obese children is associated with variations of unconjugated steroids like androgens and corticoids ( 1 , 2 , 6 ). In addition, we analyzed whether cardiovascular
Search for other papers by Anette Lundqvist in
Google Scholar
PubMed
Search for other papers by Herbert Sandström in
Google Scholar
PubMed
Search for other papers by Torbjörn Bäckström in
Google Scholar
PubMed
program and insufficient competence in the Swedish language. Blood sampling for allopregnanolone analysis was conducted in gestational weeks 12 and 35, referred to in the tables as sampling occasions 1 and 2. The internal loss was that one woman provided
Search for other papers by Monika Karczewska-Kupczewska in
Google Scholar
PubMed
Search for other papers by Agnieszka Nikołajuk in
Google Scholar
PubMed
Search for other papers by Magdalena Stefanowicz in
Google Scholar
PubMed
Search for other papers by Natalia Matulewicz in
Google Scholar
PubMed
Search for other papers by Irina Kowalska in
Google Scholar
PubMed
Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
the effect of age and sex, we used ANCOVA. Differences before and after the weight loss program were assessed with the paired Student’s t -test. Relationships between variables were studied with the Pearson product moment correlation analysis and with
Search for other papers by Metin Guclu in
Google Scholar
PubMed
Search for other papers by Sinem Kiyici in
Google Scholar
PubMed
Search for other papers by Zulfiye Gul in
Google Scholar
PubMed
Search for other papers by Sinan Cavun in
Google Scholar
PubMed
, including insulin, sulfonylureas and thiazolidinediones, cause weight gain instead of weight loss during the management period ( 3 ). Glucagon-like peptide-1 (GLP-1) receptor agonists are used in the treatment of patients with type 2 diabetes mellitus, and
epiWELL, LLC, Ithaca, New York, USA
Search for other papers by Magnolia Ariza-Nieto in
Google Scholar
PubMed
Search for other papers by Joshua B Alley in
Google Scholar
PubMed
Search for other papers by Sanjay Samy in
Google Scholar
PubMed
Search for other papers by Laura Fitzgerald in
Google Scholar
PubMed
Search for other papers by Francoise Vermeylen in
Google Scholar
PubMed
Search for other papers by Michael L Shuler in
Google Scholar
PubMed
Search for other papers by José O Alemán in
Google Scholar
PubMed
, 19 ). We report that high levels of MIR148A in plasma and low levels in liver DNMT1 mRNA transcripts in liver are related to adiponectin insensitivity in patients following metabolic surgery for weight loss at 12 weeks. Materials and methods
Search for other papers by Mardia López-Alarcón in
Google Scholar
PubMed
Search for other papers by Jessie N Zurita-Cruz in
Google Scholar
PubMed
Search for other papers by Alonso Torres-Rodríguez in
Google Scholar
PubMed
Search for other papers by Karla Bedia-Mejía in
Google Scholar
PubMed
Search for other papers by Manuel Pérez-Güemez in
Google Scholar
PubMed
Search for other papers by Leonel Jaramillo-Villanueva in
Google Scholar
PubMed
Search for other papers by Mario E Rendón-Macías in
Google Scholar
PubMed
Search for other papers by Jose R Fernández in
Google Scholar
PubMed
Search for other papers by Patricia Martínez-Maroñas in
Google Scholar
PubMed
screen), share a common scenario that is an adaptation in response to stress ( 6 ). Importantly, obese patients with these eating disorders have demonstrated a poor response to conventional weight loss interventions ( 6 ). Therefore, the search for
Search for other papers by Fang Lv in
Google Scholar
PubMed
Search for other papers by Xiaoling Cai in
Google Scholar
PubMed
Search for other papers by Chu Lin in
Google Scholar
PubMed
Search for other papers by Tianpei Hong in
Google Scholar
PubMed
Search for other papers by Xiaomei Zhang in
Google Scholar
PubMed
Search for other papers by Zhufeng Wang in
Google Scholar
PubMed
Search for other papers by Huifang Xing in
Google Scholar
PubMed
Search for other papers by Guizhi Zong in
Google Scholar
PubMed
Search for other papers by Juming Lu in
Google Scholar
PubMed
Search for other papers by Xiaohui Guo in
Google Scholar
PubMed
Search for other papers by Jing Wu in
Google Scholar
PubMed
Search for other papers by Leili Gao in
Google Scholar
PubMed
Search for other papers by Xianghai Zhou in
Google Scholar
PubMed
Search for other papers by Xueyao Han in
Google Scholar
PubMed
Search for other papers by Linong Ji in
Google Scholar
PubMed
. It was demonstrated that weight loss could result in various metabolic benefits, including glycemic control, blood pressure improvement, and lipid profile management ( 7 , 8 , 9 ). In patients with T2D, weight loss was associated with a reduced risk
Search for other papers by Thomas Reinehr in
Google Scholar
PubMed
Search for other papers by Alexandra Kulle in
Google Scholar
PubMed
Search for other papers by Juliane Rothermel in
Google Scholar
PubMed
Search for other papers by Caroline Knop-Schmenn in
Google Scholar
PubMed
Search for other papers by Nina Lass in
Google Scholar
PubMed
Search for other papers by Christina Bosse in
Google Scholar
PubMed
Search for other papers by Paul-Martin Holterhus in
Google Scholar
PubMed
primary outcome was the comparison calculated by Kruskal–Wallis test of the changes of four key steroid hormones in the four groups: (1) no PCOS and no weight loss, (2) PCOS and no weight loss, (3) no PCOS and weight loss and (4) PCOS and weight loss